Fully funded (and no tuition) PhD program in psychiatric, translational research and basic Neuroscience with the option for a residency track for medical doctors

We welcome applications starting on August 15, 2024 for a start in fall 2025 (deadline October 31, 2024).

The International Max Planck Research School for Translational Psychiatry (IMPRS-TP) is offering PhD positions in molecular, cellular, and systemic psychiatric research to outstanding students. During the course of their studies, students are exposed to a wide range of scientific questions and methods covering molecular medicine, neuroscience, and clinical psychiatry. Methods range from molecular genetics over animal models to neuroimaging and computational approaches.

Research in a translational setting

In addition to traditional PhD positions, IMPRS-TP offers a unique integrated PhD/residency program in psychiatry to exceptional medical doctors. Highlighting the translational facet, doctorate students will receive insights into clinical aspects of the disease, and trainee medical doctors gain PhD level research expertise while also developing their clinical skills.

Receive exceptional training for a successful career in research, clinic, and academia!

Structured curriculum: Core Courses | Lecture Series | Methods Workshops | Transferable Skills

Work in an environment of scientific excellence and interdisciplinary collaboration

IMPRS-TP is a joint initiative of leading scientists from the Max Planck Institutes of Psychiatry and Biological Intelligence and the Ludwig Maximilians Universität, Munich. Further collaborations have been established with the Helmholtz Center Munich, the Munich Medical Research School (MMRS), the Graduate School of Systemic Neurosciences (GSN) and King’s College London, UK.